Memorial Sloan-Kettering experts discuss the impact that cancer and its treatment can have on female fertility, and options for building a family after treatment ends.
Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan-Kettering have the benefit of an entire team of physicians having input into their care.
Dr. Chi, Deputy Chief of the Gynecology Service, talks about the way Memorial Sloan-Kettering’s research and state-of-the-art care help women with ovarian, cervical, and uterine cancers.
Dr. Barakat explains the latest surgical techniques for improving outcomes and quality of life in women with cervical, ovarian, and other gynecologic cancers.
Dr. Abu-Rustum, Director of Minimally Invasive Surgery for the Gynecology Service, discusses how the gynecologic cancer care team treats each woman with an individualized approach.
Dr. Barakat will serve as president of two prestigious societies for gynecologic cancer, allowing him to influence how women with these cancers are cared for both in the United States and around the world.
A team of surgeons led by Nadeem Abu-Rustum has pioneered an approach for treating women with early-stage gynecologic cancers that improves quality of life.
Medical oncologist Paul Sabbatini, a specialist in treating gynecologic cancers, leads a clinical research program seeking to improve treatments for ovarian cancer by harnessing the power of the immune system.
Memorial Sloan-Kettering physicians Yukio Sonoda and Nadeem Abu-Rustum were joined by cancer survivors and their children to celebrate 10 years of Memorial Sloan-Kettering’s radical trachelectomy program.
Gynecologic surgeon Carol Brown commented on a study that shows that the infection rate of human papillomavirus (HPV), the main cause of cervical cancer, decreased by 56 percent since the HPV vaccine was introduced in 2006.
Gynecologic Medical Oncology Service Chief Carol Aghajanian applauded a study that showed that using vinegar to screen for cervical cancer is an effective, low-cost alternative to the Pap smear and can help reduce the burden of disease in developing countries.
Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan-Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist.